UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B2 Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

Journal of medicinal chemistry, 2004-05, Vol.47 (11), p.2853-2863

2004

Volltextzugriff (PDF)

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614

European journal of pharmacology, 2004-06, Vol.494 (2), p.273-281

2004

Volltextzugriff (PDF)

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 1. Construction of the Basic Framework

Journal of medicinal chemistry, 1998-02, Vol.41 (4), p.564-578

1998

Volltextzugriff (PDF)

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2-a]pyridine Moiety

Journal of medicinal chemistry, 1998-10, Vol.41 (21), p.4062-4079

1998

Volltextzugriff (PDF)

The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657

British journal of pharmacology, 1997-02, Vol.120 (4), p.617-624

1997

Volltextzugriff (PDF)

The identification of an orally active, nonpeptide bradykinin B 2 receptor antagonist, FR173657

British journal of pharmacology, 2009-02, Vol.120 (4), p.617-624

2009

Volltextzugriff (PDF)

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation

Journal of medicinal chemistry, 1998-11, Vol.41 (23), p.4587-4598

1998

Volltextzugriff (PDF)

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 2. Overcoming the Species Difference between Guinea Pig and Man

Journal of medicinal chemistry, 1998-10, Vol.41 (21), p.4053-4061

1998

Volltextzugriff (PDF)

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B 2 Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

Journal of medicinal chemistry, 2004-05, Vol.47 (11), p.2853-2863

2004

Volltextzugriff (PDF)

Nonpeptide Mimic of Bradykinin with Long-Acting Properties at the Bradykinin B2 Receptor

Molecular pharmacology, 1997-07, Vol.52 (1), p.16-20

1997

Volltextzugriff (PDF)

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997

British journal of pharmacology, 1998-06, Vol.124 (3), p.441-446

1998

Volltextzugriff (PDF)

Pharmacological characterization of a nonpeptide bradykinin B 2 receptor antagonist, FR165649, and agonist, FR190997

British journal of pharmacology, 2009-02, Vol.124 (3), p.441-446

2009

Volltextzugriff (PDF)

Studies on 5-Lipoxygenase Inhibitors. I. Synthesis and 5-Lipoxygenase-Inhibitory Activity of Novel Hydroxamic Acid Derivatives

Chemical and Pharmaceutical Bulletin, 1998/06/15, Vol.46(6), pp.966-972

1998

Volltextzugriff (PDF)

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344

European journal of pharmacology, 1997-08, Vol.333 (1), p.79-86

1997

Volltextzugriff (PDF)

A New Series of Highly Potent Non-Peptide Bradykinin B2 Receptor Antagonists Incorporating the 4-Heteroarylquinoline Framework. Improvement of Aqueous Solubility and New Insights into Species Difference

Journal of medicinal chemistry, 2004-03, Vol.47 (7), p.1617-1630

2004

Volltextzugriff (PDF)

A New Series of Highly Potent Non-Peptide Bradykinin B 2 Receptor Antagonists Incorporating the 4-Heteroarylquinoline Framework. Improvement of Aqueous Solubility and New Insights into Species Difference

Journal of medicinal chemistry, 2004-03, Vol.47 (7), p.1617-1630

2004

Volltextzugriff (PDF)

Studies on 5-Lipoxygenase Inhibitors. II. Discovery, Optical Resolution and Enantioselective Synthesis of FR110302, a Highly Potent Non-redox Type-5-Lipoxygenase Inhibitor

Chemical and Pharmaceutical Bulletin, 1998/10/15, Vol.46(10), pp.1556-1565

1998

Volltextzugriff (PDF)

A New Class of Nonpeptide Bradykinin B2 Receptor Ligand, Incorporating a 4-Aminoquinoline Framework. Identification of a Key Pharmacophore To Determine Species Difference and Agonist/Antagonist Profile

Journal of medicinal chemistry, 2004-05, Vol.47 (10), p.2667-2677

2004

Volltextzugriff (PDF)

A Novel Class of Orally Active Non-Peptide Bradykinin B 2 Receptor Antagonists. 1. Construction of the Basic Framework

Journal of medicinal chemistry, 1998-02, Vol.41 (4), p.564-578

1998

Volltextzugriff (PDF)

A Novel Class of Orally Active Non-Peptide Bradykinin B 2 Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2- a ]pyridine Moiety

Journal of medicinal chemistry, 1998-10, Vol.41 (21), p.4062-4079

1998

Volltextzugriff (PDF)

A New Class of Nonpeptide Bradykinin B 2 Receptor Ligand, Incorporating a 4-Aminoquinoline Framework. Identification of a Key Pharmacophore To Determine Species Difference and Agonist/Antagonist Profile

Journal of medicinal chemistry, 2004-05, Vol.47 (10), p.2667-2677

2004

Volltextzugriff (PDF)

A Novel Class of Orally Active Non-Peptide Bradykinin B 2 Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation

Journal of medicinal chemistry, 1998-11, Vol.41 (23), p.4587-4598

1998

Volltextzugriff (PDF)

Synthesis 8-epi-Kifunensine

Chemical and Pharmaceutical Bulletin, 1991/06/25, Vol.39(6), pp.1397-1401

1991

Volltextzugriff (PDF)

Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks

Journal of medicinal chemistry, 2004-05, Vol.47 (11), p.2853-2863

2004

Volltextzugriff (PDF)

A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile

Journal of medicinal chemistry, 2004-05, Vol.47 (10), p.2667-2677

2004

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B2 Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 1. Construction of the Basic Framework

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2-a]pyridine Moiety

The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657

The identification of an orally active, nonpeptide bradykinin B 2 receptor antagonist, FR173657

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation

A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 2. Overcoming the Species Difference between Guinea Pig and Man

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B 2 Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

Nonpeptide Mimic of Bradykinin with Long-Acting Properties at the Bradykinin B2 Receptor

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997

Pharmacological characterization of a nonpeptide bradykinin B 2 receptor antagonist, FR165649, and agonist, FR190997

Studies on 5-Lipoxygenase Inhibitors. I. Synthesis and 5-Lipoxygenase-Inhibitory Activity of Novel Hydroxamic Acid Derivatives

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344

A New Series of Highly Potent Non-Peptide Bradykinin B2 Receptor Antagonists Incorporating the 4-Heteroarylquinoline Framework. Improvement of Aqueous Solubility and New Insights into Species Difference

A New Series of Highly Potent Non-Peptide Bradykinin B 2 Receptor Antagonists Incorporating the 4-Heteroarylquinoline Framework. Improvement of Aqueous Solubility and New Insights into Species Difference

Studies on 5-Lipoxygenase Inhibitors. II. Discovery, Optical Resolution and Enantioselective Synthesis of FR110302, a Highly Potent Non-redox Type-5-Lipoxygenase Inhibitor

A New Class of Nonpeptide Bradykinin B2 Receptor Ligand, Incorporating a 4-Aminoquinoline Framework. Identification of a Key Pharmacophore To Determine Species Difference and Agonist/Antagonist Profile

A Novel Class of Orally Active Non-Peptide Bradykinin B 2 Receptor Antagonists. 1. Construction of the Basic Framework

A Novel Class of Orally Active Non-Peptide Bradykinin B 2 Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2- a ]pyridine Moiety

A New Class of Nonpeptide Bradykinin B 2 Receptor Ligand, Incorporating a 4-Aminoquinoline Framework. Identification of a Key Pharmacophore To Determine Species Difference and Agonist/Antagonist Profile

A Novel Class of Orally Active Non-Peptide Bradykinin B 2 Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation

Synthesis 8-epi-Kifunensine

Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks

A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile

Suchergebnisse filtern